MACC1 - a novel target for solid cancers

Item Type:	Review
Title:	MACC1 - a novel target for solid cancers
Creators Name:	Stein, U.
Abstract:	Introduction: The metastatic dissemination of primary tumors is directly linked to patient survival in many tumor entities. The previously undescribed gene metastasis-associated in colon cancer 1 (MACC1) was discovered by genome-wide analyses in colorectal cancer (CRC) tissues. MACC1 is a tumor stage-independent predictor for CRC metastasis linked to metastasis-free survival. Areas covered: In this review, the discovery of MACC1 is briefly presented. In the following, the overwhelming confirmation of these data is provided supporting MACC1 as a new remarkable biomarker for disease prognosis and prediction of therapy response for CRC and also for a variety of additional forms of solid cancers. Lastly, the potential clinical utility of MACC1 as a target for prevention or restriction of tumor progression and metastasis is envisioned. Expert opinion: MACC1 has been identified as a prognostic biomarker in a variety of solid cancers. MACC1 correlated with tumor formation and progression, development of metastases and patient survival representing a decisive driver for tumorigenesis and metastasis. MACC1 was also demonstrated to be of predictive value for therapy response. MACC1 is a promising therapeutic target for anti-tumor and anti-metastatic intervention strategies of solid cancers. Its clinical utility, however, must be demonstrated in clinical trials.
Keywords:	Intervention, MACC1, Prediction, Prognosis, Solid Cancer, Animals
Source:	Expert Opinion on Therapeutic Targets
ISSN:	1472-8222
Publisher:	Informa Healthcare
Volume:	17
Number:	9
Page Range:	1039-1052
Date:	September 2013
Official Publication:	https://doi.org/10.1517/14728222.2013.815727
PubMed:	View item in PubMed

Repository Staff Only: item control page